Inventor
TARBY CHRISTINE M
US21 patents
⚠️ This page may combine multiple inventors who share the name “TARBY CHRISTINE M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
8 patentsUS9273057B2Mar 1, 2016
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO29 citations93
US11554120B2Jan 17, 2023
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
BRISTOL MYERS SQUIBB CO4 citations74
US9556178B2Jan 31, 2017
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US8940736B2Jan 27, 2015
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US12485123B2Dec 2, 2025
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists
BRISTOL MYERS SQUIBB CO0 citations52
US7186830B2Mar 6, 2007
Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US6844340B2Jan 18, 2005
Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US12037323B2Jul 16, 2024
Uracil derivatives as Mer-AXL inhibitors
BRISTOL MYERS SQUIBB CO0 citations45
INNATE TUMOR IMMUNITY INC
5 patentsUS11344543B2May 31, 2022
NLRP3 modulators
INNATE TUMOR IMMUNITY INC2 citations72
US12391675B2Aug 19, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US12171756B2Dec 24, 2024
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US12150937B2Nov 26, 2024
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations51
US12187706B2Jan 7, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations50